SCHEMBL20599703

SCHEMBL20599703

CN([C]1CCCCC1)S(C)(=O)=O

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135636 0.66
SCHEMBL1682326 0.62
SCHEMBL23706655 0.61 TRIM24 (0.35) SMN1; SMN2
Cyclohexane SCHEMBL27829858 0.60 KDM4E (0.67) KMT2A
Dimethyl Sulfone SCHEMBL1813999 0.60
Cyclohexanone SCHEMBL670911 0.58 TRIM24 (0.61) KMT2A
SCHEMBL18393768 0.58
Trimethylammonium SCHEMBL27805383 0.58 TRIM24 (0.73) KMT2ASMN1; SMN2
Cyclohexanone SCHEMBL27426815 0.58 TRIM24 (0.73) KMT2ASMN1; SMN2
SCHEMBL23706714 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3645516-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS Janssen Pharmaceutica NV (BE) 2020-05-06 EP disclosed
WO-2019001420-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS JANSSEN PHARMACEUTICA NV (BE) 2019-01-03 WO disclosed